School of Medicine

Showing 1-3 of 3 Results

  • Xiaokang Wu

    Xiaokang Wu

    Postdoctoral Scholar, Cardiovascular Institute

    BioDr. Wu completed her medical degree and a Ph.D. in clinical medicine from West China Medical College. Following this, she underwent postdoctoral training at the Smidt Heart Institute of Cedars-Sinai Medical Center, where her research centered on endovascular inflammation, calcium regulation in HFpEF (Heart Failure with Preserved Ejection Fraction), and the potential of Cardiosphere-derived cells (CDCs) and their exosomes (CDCexo) in heart failure treatment. Building on her proficiency in calcium handling and cardiosphere-derived cell-based therapies in rodent models, Dr. Wu became a part of the Stanford Cardiovascular Institute. Here, she delved deeper into regenerative medicine solutions for cardiovascular ailments. Currently, Dr. Wu spearheads research on transthyretin cardiac amyloidosis (ATTR), a rare and devastating protein misfolding disease. Utilizing iPSC, animal models, and human samples, her pioneering work promises significant insights into this life-threatening condition, aiming to enhance patient outcomes.